Radiofrequency ablation of stage <scp>IA</scp> non–small cell lung cancer in medically inoperable patients: Results from the <scp>A</scp>merican <scp>C</scp>ollege of <scp>S</scp>urgeons <scp>O</scp>ncology <scp>G</scp>roup <scp>Z</scp>4033 (<scp>A</scp>lliance) trial

Abstract

RFA is a single, minimally invasive procedure that is well tolerated in medically inoperable patients, does not adversely affect pulmonary function tests, and provides a 2-year overall survival rate that is comparable to the rate reported after stereotactic body radiotherapy in similar patients.